Please select the option that best describes you:
Topics:
Neurology • General Neurology
What are your ISC 2026 top takeaways?
Answer from: at Academic Institution
The most important presentation was the OCEANIC-STROKE trial showing that asundexian plus antiplatelet therapy was superior to antiplatelet therapy for secondary stroke prevention. The drug will likely be FDA-approved and change clinical practice. The CHOICE-2 trial of adjunctive i.a. thrombolysis a...
Sign In or Register to read more